Literature DB >> 34001561

Lactobacillus plantarum Reduces Low-Grade Inflammation and Glucose Levels in a Mouse Model of Chronic Stress and Diabetes.

Hyun Seong Youn1, Jong-Hwa Kim2, Ji Soo Lee1, Yeo Yeong Yoon1, Seong Jun Choi1, Joo Young Lee1, Wonyong Kim2, Kwang Woo Hwang1.   

Abstract

This study aimed to examine the effects of Lactobacillus plantarum, a lactic acid bacteria strain isolated from kimchi, on the development of low-grade inflammation and type 2 diabetes mellitus (T2DM) exacerbated by chronic stress. C57BL/6 mice were fed either a high-fat diet (HFD) and randomized into an HFD group or a group that was fed an HFD and subjected to chronic cold exposure-related stress (HFDS), or mice were fed a normal diet (ND) and randomized into an ND group or a group that was fed an ND and subjected to chronic cold exposure-related stress (NDS). Lactobacillus plantarum LRCC5310 (108, 1010 CFU) and LRCC5314 (108, 1010 CFU) as well as L. gasseri BNR17 (108 CFU), as a positive control, were administered orally twice every day to all the mice for 12 weeks. The expression of Glut4 and adiponectin, main glucose transporter-related genes, was upregulated in the LRCC5310- and LRCC5314-treated groups. Levels of serum proinflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-6 [IL-6]) and of mRNAs of proinflammatory genes (Tnf-α, Il-6, Ccl2, leptin) were elevated in HFDS mice. The expression of proinflammatory genes was downregulated in LRCC5310- and LRCC5314-treated groups; this was not the case for Tnf-α expression in HFDS mice. Levels of serum corticosterone and mRNA levels of stress-related genes (Npy, Y2r) were decreased in lactic acid bacteria (LAB)-fed groups, with only LRCC5314 downregulating Npy expression in HFDS mice. These results suggest that the LAB strains can normalize the expression of metabolic genes, inhibit inflammatory responses, and suppress stress in HFDS mice.

Entities:  

Keywords:  gut-brain axis; high-fat diet; inflammation; insulin resistance; lactic acid bacteria; stress; type 2 diabetes

Mesh:

Substances:

Year:  2021        PMID: 34001561      PMCID: PMC8284940          DOI: 10.1128/IAI.00615-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 2.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

Authors:  Nathalie Esser; Sylvie Legrand-Poels; Jacques Piette; André J Scheen; Nicolas Paquot
Journal:  Diabetes Res Clin Pract       Date:  2014-04-13       Impact factor: 5.602

Review 3.  IL-6 signalling pathways and the development of type 2 diabetes.

Authors:  Mohamad Akbari; Vahideh Hassan-Zadeh
Journal:  Inflammopharmacology       Date:  2018-03-05       Impact factor: 4.473

4.  Leptin and Inflammation.

Authors:  Noriko Iikuni; Queenie Lai Kwan Lam; Liwei Lu; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Immunol Rev       Date:  2008-05-01

5.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

Authors:  G S Hotamisligil; P Arner; J F Caro; R L Atkinson; B M Spiegelman
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor.

Authors:  Kaiping Yang; Haiyan Guan; Edith Arany; David J Hill; Xiang Cao
Journal:  FASEB J       Date:  2008-03-06       Impact factor: 5.191

7.  Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials.

Authors:  Kecheng Yao; Linghai Zeng; Qian He; Wei Wang; Jiao Lei; Xiulan Zou
Journal:  Med Sci Monit       Date:  2017-06-22

Review 8.  Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation.

Authors:  Chang Xia; Xiaoquan Rao; Jixin Zhong
Journal:  J Diabetes Res       Date:  2017-01-31       Impact factor: 4.011

Review 9.  Gut microbiota, probiotics and diabetes.

Authors:  Aline Corado Gomes; Allain Amador Bueno; Rávila Graziany Machado de Souza; João Felipe Mota
Journal:  Nutr J       Date:  2014-06-17       Impact factor: 3.271

10.  Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes.

Authors:  Woo Jin Choi; Hye Jin Dong; Hyun Uk Jeong; Dong Wook Ryu; Soo Min Song; Yu Ri Kim; Hyun Ho Jung; Tai Hoon Kim; Yeung-Hyen Kim
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

View more
  2 in total

1.  Lactiplantibacillus plantarum LRCC5314 includes a gene for serotonin biosynthesis via the tryptophan metabolic pathway.

Authors:  Jiseon Jeong; Yunjeong Lee; Seokmin Yoon; Jong-Hwa Kim; Wonyong Kim
Journal:  J Microbiol       Date:  2021-12-04       Impact factor: 3.422

2.  Evaluation of Probiotic and Antidiabetic Attributes of Lactobacillus Strains Isolated From Fermented Beetroot.

Authors:  V B Chandana Kumari; Sujay S Huligere; Ramith Ramu; Shrisha Naik Bajpe; M Y Sreenivasa; Ekaterina Silina; Victor Stupin; Raghu Ram Achar
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.